The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

Today, Jan. 23, 2026, profit taking and fresh glioblastoma survival data weighed on a soaring biotech stock. ImmunityBio ( ...

Sana Biotechnology's favorable Phase 1 trial could rapidly re-rate the stock even higher, especially since it targets a ...

The words “sure-fire” and biotechnology stocks rarely go together. This is a sector of the stock market that carries ...

Our senior market strategist explains which ETFs offer exposure to high-powered biotech growth, without T. Rex-sized risk.

This biotech has candidates in late-stage clinical development.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Carvykti sales surge, MRD FDA guidance speeds label expansion, and strong cash runway. Click for more on LEGN stock.

The shares have climbed on every trading day so far in 2026. The streak looks set to continue.

Can it become the next biotech leader?

Shares of biotech companies were outpacing the broader market on Thursday. The State Street SPDR S&P Biotech ETF was up 2.7%, compared with the 0.8% gain of the S&P 500. A significant portion of these ...